ZANAMIVIR HYDRATE Cas:139110-80-8

We are ZANAMIVIR HYDRATE CAS:139110-80-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name: ZANAMIVIR HYDRATE CAS NO: 139110-80-8

 

Synonyms:

5-acetamido-4-guanidino-2,3,4,5-tetradeoxy-D-glycero-D-galacto-non-2-enopyranosonic acid;

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid 4-Guanidino-Neu5Ac2en;

Zanamivir Hydrate;

 

Chemical & Physical Properties:

Appearance: Colorless crystalline solid

Assay :≥99.0%

Density: 1.75 g/cm33

Melting Point: 256℃ (dec.)

Index of Refraction: 1.679

 

Safety Information:

Symbol: GHS07

Signal Word: Warning

Hazard Statements: H302-H315-H319-H335

Precautionary Statements: P261-P305 + P351 + P338

Hazard Code: Xn

Risk Phrases: 22-36/37/38

Safety Phrases: 26

 

Zanamivir INN is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Related Products:4-Oxazolecarboxaldehyde, 5-[1,1′-biphenyl]-4-yl- manufacturer | 2′,5′-di-O-benzyl-3′-O-α-D-xylopyranosyladenosine supplier | 2-(((2-oxo-2-phenylethyl)thio)carbonothioyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid producer.